A new review including over 100 clinical trials has found that no induction method was clearly effective than low-dose vaginal misoprostol, although some methods were less effective and safety ...
Background: Rates of labour induction are increasing. We conducted this systematic review to assess the evidence supporting use of each method of labour induction. Methods: We listed methods of labour ...
Induction of labor is a routinely applied obstetric intervention designed to stimulate uterine contractions when delaying delivery poses a risk to maternal or neonatal health. A range of cervical ...
This Women's Health Week, we spoke with Dr. Vidanka Vasilevski from the Center for Quality and Patient Safety Research within Deakin's Institute for Health Transformation about her research published ...
Please provide your email address to receive an email when new articles are posted on . Compared with expectant management, inducing labor at 39 weeks’ gestation may be cost-effective for nulliparas ...
In the first study of its kind, researchers at RCSI University of Medicine and Health Sciences and the Rotunda Hospital, Dublin have shown that it is safe for first-time mothers to spend the first 24 ...
OBJECTIVE To evaluate if induction of labour at 41 weeks improves perinatal and maternal outcomes in women with a low risk pregnancy compared with expectant management and induction of labour at 42 ...
ANN ARBOR, Mich. – In recent years, experts have debated whether most birthing individuals would benefit from labor induction once they reach a certain stage of pregnancy. But a new statewide study in ...
What would it be like if a pregnant person who's close to full term, but not showing signs of delivery, was able to be induced at home? That's the question Dell Medical School researchers are studying ...
A new study suggests that increasing rates of induction of labor (IOL) of pregnant women and people in the UK, without considering the accompanying, real-world impact on staffing workloads and patient ...
The authors found that women allocated to extra-amniotic F2α prostaglandins were more likely to be not vaginally delivered within 24 hours than women receiving vaginal misoprostol (1 trial, 152 women, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results